Search clinical trials for: Cohort

Total 2195 results

GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Kurume University
Eisai Inc.; Mebix Inc

Completed

An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Insomnia

Japan
Ikena Oncology
Gilead Sciences

Terminated

A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Breast Cancer | Head and Neck Cancer | Gynecologic Cancer | Colorectal Cancer | Pancreatic Cancer | Gastric Adenocarcinoma | Lung Adenocarcinoma | Advanced Solid Tumor

United States
Center for Epidemiology and Health Research, Germany
Abbott Products Operations AG

Terminated

Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy (PEARLY)

Early Pregnancy Bleeding | Recurrent Pregnancy Loss

Germany
Masonic Cancer Center, University of Minnesota

Completed

Radiation and Combination Immunotherapy for Melanoma

Metastatic Melanoma

United States
University of Milano Bicocca

Recruiting

The Natural History of Hospitalized COVID-19 Patients (STORM)

Sars-CoV2

Italy
National Health Research Institutes, Taiwan
China Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical... and other collaborators

Not yet recruiting

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

GEP-NET

Taiwan
Bausch Health Americas, Inc.

Completed

A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease (Fipamezole)

Parkinson's Disease

United States
University of Alabama at Birmingham

Terminated

CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients (BRCA)

Ovarian Cancer | Resistant BRCA Wild-Type Ovarian Cancer

United States
Insmed Incorporated

Completed

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

Bronchiectasis

United States, United Kingdom, Bulgaria, India, Serbia, Ukraine, Greece, Hungary, Poland
Azienda Policlinico Umberto I
University of Roma La Sapienza

Completed

An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge) (RalAge)

HIV
Yale University

Completed

A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

Opioid Dependence

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir

Infection, Human Immunodeficiency Virus

United States, France, Spain, Canada, Italy
Hospices Civils de Lyon

Not yet recruiting

Impact of the Covid-19 on RSV (IPCoVRS-2)

RSV Infection | Rhinovirus

France
Hospices Civils de Lyon

Not yet recruiting

Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon (IPCoVRS-2)

Rhinovirus | RSV Infection in Children Less Than 5 Years of Age

France
Centre Leon Berard

Recruiting

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. (MegaMOST)

Malignant Solid Tumor

France
Hospices Civils de Lyon

Not yet recruiting

Impact of Covid-19 on Rhinovirus Epidemic (IPCoRV)

Rhinovirus
Hospices Civils de Lyon

Completed

Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic (IPCoVRS)

RSV Infection

France
Jemincare
Zhejiang Hangyu Pharmaceutical Co., Ltd

Recruiting

Phase 1 Clinical Study of JMKX003142 Tablets

Safety and Tolerability

China
Stanford University

Completed

Risk Factors for Long-term Opioid Use

Pain Syndrome
Shaare Zedek Medical Center

Recruiting

Prodromal Parkinsonian Features in GBA1 Mutation Carriers

Healthy | Gaucher Disease, Type 1

Israel
Jemincare

Recruiting

Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects

Safety and Tolerability

China
Versailles Hospital

Completed

A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML (OPTIMIMATINIB)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

France
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (XW003)

Obesity | Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis

Australia
Fisher and Paykel Healthcare

Completed

CPAP Device In-lab Assessment NZ

Obstructive Sleep Apnea

New Zealand
UL-PIRE Africa Center
West African Consortium for Clinical Research on Epidemic Pathogens (WAC-CREP)

Not yet recruiting

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Ebola Virus Disease

Liberia
Efficacy Care R&D Ltd
Memorial Hermann Hospital; CRG Medical, Inc.

Unknown

Postoperative Respiratory Abnormalities (AI-ARF)

Shock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditions

United States
Compugen Ltd

Recruiting

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Multiple Myeloma | Ovarian Cancer | Lung Cancer | Advanced Cancer | Colon Cancer | Plasma Cell Neoplasm | HNSCC | Microsatellite Stable Colorectal Carcinoma | MSS-CRC

United States
University Hospital, Bordeaux
Bordeaux PharmacoEpi

Recruiting

Economic Evaluation of Prostatic Urethral Lift (ECOLIFT)

Benign Prostatic Hyperplasia

France
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Hepatitis B | HBV

Korea, Republic of, United States, Canada, Australia, New Zealand
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

Hepatitis C

United States, Puerto Rico
Cancer Institute and Hospital, Chinese Academy...

Completed

Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer (MIS-MRC)

Locally Advanced Rectal Cancer | Distant Metastasis

China
Telavant, Inc.
Pfizer

Completed

Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants

Healthy

Japan
Shanghai Henlius Biotech

Active, not recruiting

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

Head and Neck Squamous Cell Carcinoma

China
Groupe Hospitalier Paris Saint Joseph

Completed

Study of the Social and Psychological Consequences of ICU Hospitalization

Intensive Care Units

France
Centre Hospitalier Universitaire, Amiens

Unknown

Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema? (REPLIPO)

Exanthema | Hemopathy | HHV6

France
H. Lundbeck A/S

Completed

Observational Study in Multiple System Atrophy (TALISMAN)

Multiple System Atrophy

China
Spectrum Health Hospitals
Millennium Pharmaceuticals, Inc.

Completed

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Hematological Malignancy

United States
Oramed, Ltd.
Integrium

Completed

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Sun Yat-sen University

Recruiting

Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colorectal Cancer (PICC)

Colorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)

China
National Heart, Lung, and Blood Institute (NHLBI)
Novartis

Recruiting

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Severe Aplastic Anemia

United States
AstraZeneca

Active, not recruiting

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer (OlympiaN)

Breast Cancer

United States, Belgium, Italy, Spain, United Kingdom, Germany, Austria, Israel, Australia
Centre Hospitalier Universitaire de Nīmes

Completed

AUgmented REality for the Visually Impaired - Part 1 (AUREVI 1)

Glaucoma | Retinitis Pigmentosa

France
Hospices Civils de Lyon

Completed

Prematurity at the Limit of Viability (PRELIVIA)

Very Preterm Maturity of Infant

France
Centocor, Inc.

Completed

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Pulmonary Disease, Chronic Obstructive | COPD

United States
University of Houston

Completed

Toric Contact Lens Performance Study

Astigmatism

United States
Phost'In Therapeutics

Recruiting

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours (PhAST)

Glioblastoma Multiforme | Metastatic Cancer | Advanced Solid Tumor | Malignant Tumor

Italy, France
Austin Health
AstraZeneca; Olivia Newton-John Cancer Research Institute

Completed

A Trial of Radiotherapy and Durvalumab in DLBCL and FL (RaDD)

Follicular Lymphoma | Diffuse Large B Cell Lymphoma

Australia
ProQR Therapeutics

Completed

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Stellar)

Eye Diseases | Retinitis Pigmentosa | Eye Diseases, Hereditary | Vision Disorders | Retinal Disease | Eye Disorders Congenital | Usher Syndrome Type 2 | Deaf Blind

United States, Canada, France
Centre Hospitalier Universitaire, Amiens

Recruiting

Impact of Hypnosis for Performing Lumbar Infusion Tests (HYPNINF)

Pain | Anxiety | Hypnosis | Hydrocephalus

France

Search clinical trials for: Cohort

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations